We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Sanofi Gets Untitled Letter for Taxotere Journal Reprint Carrier
Sanofi Gets Untitled Letter for Taxotere Journal Reprint Carrier
May 14, 2009
The FDA cited Sanofi-Aventis for making unsubstantiated superiority claims for its breast cancer chemotherapy Taxotere in a professional journal reprint carrier distributed at the American Society of Clinical Oncology annual meeting last June.